Quantcast

Latest Hodgkin's lymphoma Stories

2014-06-09 14:34:42

Rockefeller University Press A new study in The Journal of Experimental Medicine reveals that a high-risk group of patients with follicular lymphoma could benefit from a novel drug combination. Follicular lymphoma, a B cell lymphoma, is an incurable form of non-Hodgkin lymphoma that is diagnosed each year in 120,000 people worldwide. Follicular lymphoma is characterized by slow and relentless tumor growth with inevitable relapses despite intense chemotherapy. Follicular lymphomas are...

2014-06-09 12:26:41

Public Healthcare Systems in Brazil and Mexico Cover Targeted Therapies but with Indication-Specific Restrictions, According to Findings from Decision Resources Group BURLINGTON, Mass., June 9, 2014 /PRNewswire/ -- Decision Resources Group finds that targeted therapies such as MabThera (rituximab) for non-Hodgkin's lymphoma (NHL) and Velcade (bortezomib) for multiple myeloma (MM) enjoy extensive but incomplete coverage in Brazil and Mexico through complex mechanisms. To obtain reimbursement,...

2014-06-02 23:05:52

Transparency Market Research added a new report "Global Natural Killer Cell Lymphomas Market: Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store. Browse the full report: http://www.transparencymarketresearch.com/natural-killer-cell-lymphomas.html. Albany, New York (PRWEB) June 02, 2014 Lymphoma is a common blood cancer type which develops when lymphocytes multiply in an uncontrolled manner. There are two types of lymphomas- Hodgkin’s and...

2014-05-31 08:21:05

- Data include results from two Phase I studies of ABT-199/GDC-0199 in relapsed/refractory chronic lymphocytic leukemia (CLL) and various subtypes of non-Hodgkin's lymphoma (NHL) NORTH CHICAGO, Ill., May 31, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) released interim results from a Phase Ib clinical trial of ABT-199/GDC-0199, an investigational B-cell lymphoma 2 (BCL-2) selective inhibitor, in combination with rituximab (Abstract 7013). Results showed an overall response rate (ORR) of...

2014-05-19 08:29:00

WHITE PLAINS, N.Y., May 19, 2014 /PRNewswire-USNewswire/ -- Foundation Beyond Belief (FBB), a team of atheists, humanists and religious allies, just completed their second year with The Leukemia & Lymphoma Society's (LLS) Light The Night® fundraising campaign. FBB is a national partner in support of LLS's mission to find cures and ensure access to treatments for patients with blood cancers. As a Special Friend of Light The Night, FBB has raised $930,000 to date. In their first...

2014-05-15 12:28:11

Blair, Ph.D., testifies how God enabled him to live cancer-free, without treatment MAITLAND, Fla., May 15, 2014 /PRNewswire-iReach/ -- In his new book, God's Cure For Cancer: No chemotherapy, No radiation, No surgery ($14.99, paperback, 9781629522029; $6.99, e-book, 9781629522036) Weston L. Blair, Ph.D. tells the remarkable story of how God healed him from Stage 4 Non-Hodgkin's Lymphoma. The author's full recovery was made possible only through the Word of God. Furthermore, he was...

2014-04-29 16:25:50

Blair, Ph.D., testifies how God enabled him to live cancer-free, without treatment MAITLAND, Fla., April 29, 2014 /PRNewswire-iReach/ -- In his new book, God's Cure For Cancer: No chemotherapy, No radiation, No surgery ($12.99, paperback, 9781629522029; $6.99, e-book, 9781629522036) Weston L. Blair, Ph.D. tells the remarkable story of how God healed him from Stage 4 Non-Hodgkin's Lymphoma. The author's full recovery was made possible only through the Word of God. Furthermore, he was...

2014-04-29 04:21:45

- First and Only Approved Monotherapy in the EU for this Patient Population - BIRMINGHAM, England, April 29, 2014 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced the launch of PIXUVRI® (pixantrone), the first new treatment for adult patients in the United Kingdom (UK) with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (aggressive B-cell NHL), at the 54(th) annual scientific meeting of the British Society for Haematology. PIXUVRI...

2014-04-24 08:33:54

Patent covers methods of use for small molecule inhibitors in the treatment of NHL, including follicular and diffuse large B-cell lymphomas CAMBRIDGE, Mass., April 24, 2014 /PRNewswire-USNewswire/ -- Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that the U.S. Patent and Trademark Office has granted a notice of allowance for U.S. Patent Application...

2014-04-08 12:31:36

Community Leaders throughout the North Bay Area Assemble to Join LLS in the Fight against Blood Cancers SANTA ROSA, Calif., April 8, 2014 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society's (LLS) Greater Bay Area Chapter is launching its 2014 North Bay Man & Woman of the Year (MWOY) fundraising campaign, enlisting influential and compassionate community leaders as candidates competing to raise funds for blood cancer research and cures. In its second year, the North...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related